Carlos Andreu-Vilarroig
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Carlos Andreu-Vilarroig has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Rafael Jacinto Villanueva
Instituto de Matemática Multidisciplinar, Universitat Politècnica de València, Valencia, Spain
3 shared publications Rafael-Jacinto Villanueva
3 shared publicationsAlejandro Orrico-Sánchez
FISABIO Publ Hlth, Fdn Fomento Invest Sanitaria & Biomed Comunitat Va, Vaccines Res Unit, Valencia, Spain
1 shared publication- Carlos Andreu-Mateu
Hospital General Universitario de Castellón, Castellòn de la Plana, Spain
1 shared publication - Cintia Muñoz-Quiles
Vaccines Research Unit. Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana FISABIO‐Public Health Valencia Spain
1 shared publication - Cristina Santamaría
Instituto Universitario de Matemática Multidisciplinar, Universitat Politècnica de València, 46022 València, Spain
1 shared publication
Latest Publications
- Open Access
- 11 May 2026
- Published by Springer Nature in Computational and Applied Mathematics
- Vol. 45 (9)
Modelling and calibrating antibiotic resistance dynamics with uncertainty: a particle swarm optimization approach for estimating random parameters distribution
Nowadays, the rapid growth of antibiotic resistance, mainly due to the non-rational use of antibiotics, is one of the threats to global public health. In this context, mathematical modelling of the dynamics of antibiotic resistance, considering the randomness intrinsic to the biological process, would allow studying the long-term evolution of the resistance. In this work, we present an antibiotic resistance model and we propose a novel method to calibrate and estimate an empirical joint distribution of the model parameters which is representative of a real-world scenario. Unlike other approaches, our method does not assume any a priori family of parameter distributions or independence between them. The model calibration has been carried out using the Particle Swarm Optimization (PSO) evolutionary algorithm. Based on the record of their multiple evaluations, our method consists of taking a sample from the parameter space that represents equidistributedly the different zones of the error function explored by the PSO. The sample selection is carried out first with a k -means clustering, and then with two antagonistic objective functions that choose the set of solutions most representative of the data, i.e. that best fit and best capture their uncertainty within a certain confidence interval. From this final sample, an estimation of the empirical joint distribution is obtained. The method has been successfully applied to the case study: the colistin-resistant Acinetobacter baumannii dynamics in the Valencian Community, Spain. The method has been tested under different calibration conditions by varying the number of PSO iterations. The results show that the parameters distributions are representative of the data and the method has been shown to be robust under all calibration scenarios. In all cases, the model simulations of the final sample adequately fit both the calibration and validation resistance data series and capture a high proportion of randomness (around 70% or more) within the 95% confidence interval. Moreover, the empirical joint PDF has revealed the dependence or correlation between the model parameters. All in all, this contribution demonstrates the applicability of the method to a real problem and, due to its metaheuristic approach, its potential application to other mathematical modelling problems with uncertainty.
- 11 May 2026
- Published by Springer Nature in Computational and Applied Mathematics
- Vol. 45 (9)
Open AccessModelling and calibrating antibiotic resistance dynamics with uncertainty: a particle swarm optimization approach for estimating random parameters distribution
Nowadays, the rapid growth of antibiotic resistance, mainly due to the non-rational use of antibiotics, is one of the threats to global public health. In this context, mathematical modelling of the dynamics of antibiotic resistance, considering the randomness intrinsic to the biological process, would allow studying the long-term evolution of the resistance. In this work, we present an antibiotic resistance model and we propose a novel method to calibrate and estimate an empirical joint distribution of the model parameters which is representative of a real-world scenario. Unlike other approaches, our method does not assume any a priori family of parameter distributions or independence between them. The model calibration has been carried out using the Particle Swarm Optimization (PSO) evolutionary algorithm. Based on the record of their multiple evaluations, our method consists of taking a sample from the parameter space that represents equidistributedly the different zones of the error function explored by the PSO. The sample selection is carried out first with a k -means clustering, and then with two antagonistic objective functions that choose the set of solutions most representative of the data, i.e. that best fit and best capture their uncertainty within a certain confidence interval. From this final sample, an estimation of the empirical joint distribution is obtained. The method has been successfully applied to the case study: the colistin-resistant Acinetobacter baumannii dynamics in the Valencian Community, Spain. The method has been tested under different calibration conditions by varying the number of PSO iterations. The results show that the parameters distributions are representative of the data and the method has been shown to be robust under all calibration scenarios. In all cases, the model simulations of the final sample adequately fit both the calibration and validation resistance data series and capture a high proportion of randomness (around 70% or more) within the 95% confidence interval. Moreover, the empirical joint PDF has revealed the dependence or correlation between the model parameters. All in all, this contribution demonstrates the applicability of the method to a real problem and, due to its metaheuristic approach, its potential application to other mathematical modelling problems with uncertainty.
- Open Access
- 23 September 2024
- Published by Elsevier in Chaos, Solitons & Fractals
- Vol. 188
Quantifying the delay in eliminating vaccine-targeted human papillomavirus after a drop in the coverage using a lifetime sexual partners network
- 23 September 2024
- Published by Elsevier in Chaos, Solitons & Fractals
- Vol. 188
Open AccessQuantifying the delay in eliminating vaccine-targeted human papillomavirus after a drop in the coverage using a lifetime sexual partners network
- 17 September 2024
- Published by Oxford University Press (OUP) in Mathematical Medicine and Biology: A Journal of the IMA
- Vol. 41 (4) , 277-303
Calibration and comparison of SIR, SEIR/SLIR and SLAIR models for influenza dynamics: insights from the 2016-2017 season in the Valencian Community, Spain
Influenza and influenza-like illnesses pose significant challenges to healthcare systems globally. Mathematical models play a crucial role in understanding their dynamics, calibrating them to specific scenarios and making projections about their evolution over time. This study proposes a calibration process for three different but well-known compartmental models—SIR, SEIR/SLIR and SLAIR—using influenza data from the 2016–2017 season in the Valencian Community, Spain. The calibration process involves indirect calibration for the SIR and SLIR models, requiring post-processing to compare model output with data, while the SLAIR model is directly calibrated through direct comparison. Our calibration results demonstrate remarkable consistency between the SIR and SLIR models, with slight variations observed in the SLAIR model due to its unique design and calibration strategy. Importantly, all models align with existing evidence and intuitions found in the medical literature. Our findings suggest that at the onset of the epidemiological season, a significant proportion of the population (ranging from 29.08% to 43.75% of the total population) may have already entered the recovered state, likely due to immunization from the previous season. Additionally, we estimate that the percentage of infected individuals seeking healthcare services ranges from 5.7% to 12.2%. Through a well-founded and calibrated modeling approach, our study contributes to supporting, settling and quantifying current medical issues despite the inherent uncertainties involved in influenza dynamics. The full Mathematica code can be downloaded from https://munqu.webs.upv.es/software.html.
- 17 September 2024
- Published by Oxford University Press (OUP) in Mathematical Medicine and Biology: A Journal of the IMA
- Vol. 41 (4) , 277-303
Calibration and comparison of SIR, SEIR/SLIR and SLAIR models for influenza dynamics: insights from the 2016-2017 season in the Valencian Community, Spain
Influenza and influenza-like illnesses pose significant challenges to healthcare systems globally. Mathematical models play a crucial role in understanding their dynamics, calibrating them to specific scenarios and making projections about their evolution over time. This study proposes a calibration process for three different but well-known compartmental models—SIR, SEIR/SLIR and SLAIR—using influenza data from the 2016–2017 season in the Valencian Community, Spain. The calibration process involves indirect calibration for the SIR and SLIR models, requiring post-processing to compare model output with data, while the SLAIR model is directly calibrated through direct comparison. Our calibration results demonstrate remarkable consistency between the SIR and SLIR models, with slight variations observed in the SLAIR model due to its unique design and calibration strategy. Importantly, all models align with existing evidence and intuitions found in the medical literature. Our findings suggest that at the onset of the epidemiological season, a significant proportion of the population (ranging from 29.08% to 43.75% of the total population) may have already entered the recovered state, likely due to immunization from the previous season. Additionally, we estimate that the percentage of infected individuals seeking healthcare services ranges from 5.7% to 12.2%. Through a well-founded and calibrated modeling approach, our study contributes to supporting, settling and quantifying current medical issues despite the inherent uncertainties involved in influenza dynamics. The full Mathematica code can be downloaded from https://munqu.webs.upv.es/software.html.
- Open Access
- 1 September 2024
- Published by KEAI Publishing in Infectious Disease Modelling
- Vol. 9 (3) , 744-762
Mathematical modeling for estimating influenza vaccine efficacy: A case study of the Valencian Community, Spain.
Vaccine efficacy and its quantification is a crucial concept for the proper design of public health vaccination policies. In this work we proposed a mathematical model to estimate the efficacy of the influenza vaccine in a real-word scenario. In particular, our model is a SEIR-type epidemiological model, which distinguishes vaccinated and unvaccinated populations. Mathematically, its dynamics is governed by a nonlinear system of ordinary differential equations, where the non-linearity arises from the effective contacts between susceptible and infected individuals. Two key aspects of this study is that we use a vaccine distribution over time that is based on real data specific to the elderly people in the Valencian Community and the calibration process takes into account that over one influenza season a specific proportion of the population becomes infected with influenza. To consider the effectiveness of the vaccine, the model incorporates a parameter, the vaccine attenuation factor, which is related with the vaccine efficacy against the influenza virus. With this framework, in order to calibrate the model parameters and to obtain an influenza vaccine efficacy estimation, we considered the 2016-2017 influenza season in the Valencian Community, Spain, using the influenza reported cases of vaccinated and unvaccinated. In order to ensure the model identifiability, we choose to deterministically calibrate the parameters for different scenarios and we find the one with the minimum error in order to determine the vaccine efficacy. The calibration results suggest that the influenza vaccine developed for 2016-2017 influenza season has an efficacy of approximately 76.7%, and that the risk of becoming infected is five times higher for an unvaccinated individual in comparison with a vaccinated one. This estimation partially agrees with some previous studies related to the influenza vaccine. This study presents a new integrated mathematical approach to study the influenza vaccine efficacy and gives further insight into this important public health topic.
- 1 September 2024
- Published by KEAI Publishing in Infectious Disease Modelling
- Vol. 9 (3) , 744-762
Open AccessMathematical modeling for estimating influenza vaccine efficacy: A case study of the Valencian Community, Spain.
Vaccine efficacy and its quantification is a crucial concept for the proper design of public health vaccination policies. In this work we proposed a mathematical model to estimate the efficacy of the influenza vaccine in a real-word scenario. In particular, our model is a SEIR-type epidemiological model, which distinguishes vaccinated and unvaccinated populations. Mathematically, its dynamics is governed by a nonlinear system of ordinary differential equations, where the non-linearity arises from the effective contacts between susceptible and infected individuals. Two key aspects of this study is that we use a vaccine distribution over time that is based on real data specific to the elderly people in the Valencian Community and the calibration process takes into account that over one influenza season a specific proportion of the population becomes infected with influenza. To consider the effectiveness of the vaccine, the model incorporates a parameter, the vaccine attenuation factor, which is related with the vaccine efficacy against the influenza virus. With this framework, in order to calibrate the model parameters and to obtain an influenza vaccine efficacy estimation, we considered the 2016-2017 influenza season in the Valencian Community, Spain, using the influenza reported cases of vaccinated and unvaccinated. In order to ensure the model identifiability, we choose to deterministically calibrate the parameters for different scenarios and we find the one with the minimum error in order to determine the vaccine efficacy. The calibration results suggest that the influenza vaccine developed for 2016-2017 influenza season has an efficacy of approximately 76.7%, and that the risk of becoming infected is five times higher for an unvaccinated individual in comparison with a vaccinated one. This estimation partially agrees with some previous studies related to the influenza vaccine. This study presents a new integrated mathematical approach to study the influenza vaccine efficacy and gives further insight into this important public health topic.
- 30 April 2024
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 187, 105470
Analysis and prediction of long-term survival using a clinically applicable risk score based on the Electronic Health Record
- 30 April 2024
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 187, 105470
Analysis and prediction of long-term survival using a clinically applicable risk score based on the Electronic Health Record
- Open Access
- 30 November 2023
- Published by EDP Sciences in Mathematical Modelling of Natural Phenomena
- Vol. 18, 33
On the Epidemiological Evolution of Colistin-ResistantAcinetobacter Baumanniiin the City of Valencia: An Agent-Based Modelling Approach
Antibiotic resistance is one of the greatest public health threats today, mainly due to the non-rational use of antibiotics.Acinetobacter baumanniiis an example of a microorganism with high antibiotic resistance that has developed rapidly in recent years. Consequently, only a few lastresort antibiotics, such as colistin, are currently effective against it. In this work, we propose a random agent-based computational model to describe the evolution of colistin-resistantA. baumanniiin the population of Valencia (Spain) and to predict its impact both on the whole population and by age groups. The agent- based model uses a synthetic population of individuals with a vector of characteristics or state variables. These variables change over time based on a series of random events with certain conditional probabilities. The synthetic population statistical features and the probabilities have been found in demographic and hospital databases. One of these probabilities, the probability of infection by a resistant strain, has been modeled using random differential equations. The model takes into account antibiotic consumption as the primary driving force of variation and assumes non-rewersibility of resistance as the worst-case scenario. The agent-based model calibration and the selection of a real-world representative set of solutions have been carried out using the Partide Swarm Optimization evolutionary algorithm. This approach takes into account the inherent stochasticity of the model and the uncertainty of the data. Finally, projections of the incidence and absolute cases of colistin-resistantA. baumanniihave been performed. Our results suggest that, if the same consumption pattern continues, the ervolution of the colistin-resistant strain proportion will be exponential, exceeding 50% in 2025. Additionally, the results reveal that, despite the low incidence in Valencian hospitals, the impact on people over 60 years old will be more significant in terms of the number of cases. Based on these findings, it can be deduced that colistin will cense to be an effective antibiotic in the coming years, negatively impacting the human population, especially the most advanced age groups.
- 30 November 2023
- Published by EDP Sciences in Mathematical Modelling of Natural Phenomena
- Vol. 18, 33
Open AccessOn the Epidemiological Evolution of Colistin-ResistantAcinetobacter Baumanniiin the City of Valencia: An Agent-Based Modelling Approach
Antibiotic resistance is one of the greatest public health threats today, mainly due to the non-rational use of antibiotics.Acinetobacter baumanniiis an example of a microorganism with high antibiotic resistance that has developed rapidly in recent years. Consequently, only a few lastresort antibiotics, such as colistin, are currently effective against it. In this work, we propose a random agent-based computational model to describe the evolution of colistin-resistantA. baumanniiin the population of Valencia (Spain) and to predict its impact both on the whole population and by age groups. The agent- based model uses a synthetic population of individuals with a vector of characteristics or state variables. These variables change over time based on a series of random events with certain conditional probabilities. The synthetic population statistical features and the probabilities have been found in demographic and hospital databases. One of these probabilities, the probability of infection by a resistant strain, has been modeled using random differential equations. The model takes into account antibiotic consumption as the primary driving force of variation and assumes non-rewersibility of resistance as the worst-case scenario. The agent-based model calibration and the selection of a real-world representative set of solutions have been carried out using the Partide Swarm Optimization evolutionary algorithm. This approach takes into account the inherent stochasticity of the model and the uncertainty of the data. Finally, projections of the incidence and absolute cases of colistin-resistantA. baumanniihave been performed. Our results suggest that, if the same consumption pattern continues, the ervolution of the colistin-resistant strain proportion will be exponential, exceeding 50% in 2025. Additionally, the results reveal that, despite the low incidence in Valencian hospitals, the impact on people over 60 years old will be more significant in terms of the number of cases. Based on these findings, it can be deduced that colistin will cense to be an effective antibiotic in the coming years, negatively impacting the human population, especially the most advanced age groups.
- 22 October 2023
- Published by Springer Nature
- p. 112-121
A Calibration Method for Random Models with Dependent Random Parameters: The Applied Case of Tumor Growth
- 22 October 2023
- Published by Springer Nature
- p. 112-121
A Calibration Method for Random Models with Dependent Random Parameters: The Applied Case of Tumor Growth